Summary & Key Points
"From September 5 to 8, 2022, the closing of the FISSA ALERRT study at the CHU Treichville was held in the Pr Marguerite TIMITE room of the PAC-CI program."
From September 5 to 8, 2022, the closing ceremony of the FISSA ALERRT study was held in the Pr Marguerite TIMITE room at the PAC-CI Program, at Treichville University Hospital (CHU Treichville). This event was attended by the study investigators, the site supervisor, and the International and Regional Coordination of the study. It marked the end of the site’s participation in the study. The Treichville University Hospital site opened on 12/26/2019 in the Adult Medical Emergency and Pediatric Emergency departments, with Principal Investigator Pr Aristophane TANON and Site Supervisor Dr Raoul MOH. The secondary investigators, assisted in their tasks by Clinical Study Technician Patrick KOABENAN, had enrolled 668 eligible adult and child participants by the enrollment end date of 12/31/2021. The closing ceremony was led by Dr Gérard MENAN, International Project Manager, and Suzanne KOUADIO, Regional Clinical Research Associate, with support from Antoine KOUAME, Monitoring Pool Manager. For reference, the FISSA study is an observational study aimed at describing the epidemiology, clinical aspects, and management of febrile illnesses in sub-Saharan Africa. It was conducted across fifteen (15) sites in eleven (11) countries.
